March 2021 Curriculum Vitae
NAME: Robin Lester Carhart-Harris D.O.B: 31 August 1980 (40) NATIONALITY: British STATUS: Married. Two children. PRESENT POSITION: Head of Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Faculty of Medicine, Imperial College London. April 2019-present. http://www.imperial.ac.uk/psychedelic-research-centre/
POSITION from July 1st, 2021: Ralph Metzner Distinguished Professor, Director of Neuroscape Psychedelics Division, Department of. Neurology, University of California, San Francisco
PAST POSITIONS: Associative Professor, Dept. of Psychiatry, University of Oxford. July 2018- Dec 2019 Research Fellow & Group Lead, Psychedelic Research Group, Imperial College London 2015-2019 Research Associate, Neuropsychopharmacology, Imperial College London. 2009-2015
H-INDEX & CITATIONS: As of March 2021: H-index = 48 Citations = >9,400
BRIEF BIOGRAPHY: Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol, focused on the serotonin system, and an MA in Psychoanalysis from Brunel University, 2005. Robin has designed human brain imaging studies with LSD, psilocybin, MDMA and DMT, a clinical trial of psilocybin for treatment-resistant depression, a double-blind randomized controlled trial comparing psilocybin with the SSRI, escitalopram, for depression, published in the New England Journal of Medicine, and a multimodal imaging study in first time users of psilocybin. Robin has published over 100 scientific papers. He founded the Centre for Psychedelic Research at Imperial College London in April 2019, the first of its kind. In 2021, he was listed in TIME magazine’s ‘100 Next’, a list of 100 rising stars shaping the future. Also in 2021, he moved to University of California, San Francisco, becoming the Ralph Metzner Distinguished Professor in Neurology and Psychiatry. At UCSF, Robin will serve as Director of the new Psychedelics Division within the translational neuroscience Centre, Neuroscape.
ACADEMIC QUALIFICATIONS: 2005-09 PhD Psychopharmacology, Dept. Psychiatry, University of Bristol 2004-05 MA Psychoanalysis and Contemporary Society, Brunel University. 2001-04 BSc (Honours) Applied Psychology and Computing, Bournemouth University: 2.1. 1998-99 A-levels: Sociology, Psychology, Chemistry: A, B, C
GRANTS (Bold = PI on all donations unless otherwise stated): Total: >£3.8M 2021 Thomas Martin £50K 2020 Charlene Engelhard $400K 2020 Ryan Zurrer $60K 2019 Eric Grotefeld £20K 2019 Brian Rose/London Real £10K 2019 Christian Angermayer £150K 2019 Amanda Eilian $10K 2019 Alex Mosley Trust £200K 2019 Tim Ferriss $1M 2019 Anton Bilton £0.5M 2019 Singhal Foundation $1.25M 2018 Tamas family $1M 1 2018 Ad Astra Chandaria Foundation £0.25M 2012 MRC DCS grant £0.5M (not PI but named study coordinator and wrote application)
AWARDS & HONORS: 2021 TIME 100 Next, 2021: https://time.com/collection/time100-next-2021/5937720/robin-carhart-harris/ 2020 Named among world’s Top 31 medical scientists, The Times: https://www.thetimes.co.uk/article/from-pandemics-to-cancer-the-science-power-list-d23bb9b2k 2018 ABAI, BF Skinner Award 2018 2015 Junior Clinical Award, British Association of Psychopharmacology 2011 Heffter Research Institute Award 2010 Multidisciplinary Association for Psychedelic Studies (MAPS) Award 2009 Neuropsychoanalysis Foundation Award 2008 Bristol-Cardiff Young Neuroscientist Award
TEACHING & SUPERVISION OVERVIEW: Imperial College London teaching 2011-2021: BSc Medical Biosciences MSc Experimental Neuroscience MRes Experimental Neuroscience Invited teaching for: Kings (Maudsley), UCL, Barts (BSc & Masters) Clinical Psychology lecture, University of Oxford. Current Supervision: Four PhD students, 5 MSc (Imperial), 5 interns. Supervised 4 PhDs to completion & 15+ Masters students.
PhD EXAMINER: 2020 Malin Uthaug, Maastricht University. 1st supervisor = Prof Jan Ramaekers.
ADVISORY BOARDS & COMMITTEES: 2021 Advice to Australian government on psychedelic drug policy 2020-21 Advice to UK government Special Advisors on psychedelic medicine 2020 Advice to FDA on psychedelic medicine 2020 Advisor to Drug Science Psychedelic working group 2020 Oregon Psilocybin Services Training Advisory Board 2020 Requested scientific advisor to SmallpharmaÓ 2020 Scientific advisor to TRYP TherapeuticsÓ 2020 Scientific advisor to EntheonBiomedicalÓ 2020 Scientific advisor to MydecineÓ 2019 Scientific advisor to Compass PathwaysÓ 2019 Requested scientific advisor for UsonaÓ 2019 Scientific advice for OtsukaÓ 2019 Scientific advisor for Synthesis InstituteÓ 2018 European Medicine Agency. Scientific advisor to Compass PathwaysÓ 2017 Medicines & Healthcare Regulatory Authority (MHRA). Scientific advice for EleusisÓ 2016-18 MRes Translational Neuroscience. Organising Committee. Imperial College London
MEMBERSHIPS & EDITORIAL BOARDS: 2020-present Member of Association for Psychological Science 2020-present Massachusetts General Hospital, Psychedelic Research Centre, Advisory Council member 2015-present Member of the Neuropsychoanalysis Association 2016-present Member of International Society for Research on Psychedelics 2009-present British Association for Psychopharmacology 2012-present Editorial Board: Journal of Psychopharmacology 2011-present Editorial Board: Journal of Neuropsychoanalysis
CURRENT POSTDOCS: 2021-currentq Dr Selen Atasoy 2020-current Dr Taylor Lyons 2 2020-current Dr Balazs Szigeti 2020-current Dr Christopher Timmermann 2019-current Dr Leor Roseman 2019-current Dr Fernando Rosas 2019-current Dr Meg Spriggs 2019-current Dr Malin Uthaug
VISITING POSTDOCS: 2019-2020 Dr Charlotte Marshall, Coma Science Group, Liege University 2014-2015 Dr Eduardo Schenberg, University of Sao Paulo
RESEARCH ASSOCIATES: 2020-current Laura Kartner 2020-current Keri Mans 2019-current Hannes Kettner 2017-current Bruna Giribaldi
SUPERVISED PhD STUDENTS (1st supervisor unless stated): Graduated Leor Roseman, PhD Graduated Mendel Kaelen, PhD Graduated Christopher Timmermann, PhD Graduated Taylor Lyons, PhD 2019-current Lisa Luan, PhD student 2019-current Julia Bornmann, PhD student 2020-current Hannah Douglas, PhD student 2020-current Hannes Kettner, PhD student
SUPERVISED IMPERIAL MASTERS STUDENTS (Bold = awarded highest possible grade): 2020 Hannah Douglas, MSc Experimental Neuroscience 2020 Nadrah Mohamed-Izmi, MSc Experimental Neuroscience 2020 Will Roseby, MSc Experimental Neuroscience 2020 Faissal Sharif, MSc Experimental Neuroscience 2020 James Sexton, MSc Experimental Neuroscience 2019 Kevin Stevralia, MRes Translational Neuroscience 2019 Gregory Cooper, MSc Experimental Neuroscience 2019 Katie Trinci, MSc Experimental Neuroscience 2019 Pablo Mallaroni, MSc Experimental Neuroscience 2019 Joanna Kuc, MSc Experimental Neuroscience 2019 Joe Peill, MSc Experimental Neuroscience 2017 Melissa Shukuroglou, MRes, Neuroscience 2017 Meghan Good, MRes, Experimental Neuroscience 2017 Jo Wagland, BSc Medicine, Imperial College London 2016 Lisa Evans, MRes Experimental Neuroscience 2015 Kabir Nigam, MRes Experimental Neuroscience 2013 Dr Stefan Brugger, Imperial graduate in Medicine 2013 Leor Roseman, MRes Experimental Neuroscience 2012 Tytus Murphy, MRes Neuroscience
SUPERVISED EXTERNAL STUDENTS/INTERNS (Bold = awarded highest possible grade): 2020 Sebastian Hubner, MSc, Cognitive Science, University of Trento 2019 Keri Mans, MSc Clinical Neuropsychology, Maastricht University 2019 Richard Zeifman, Clinical. Psych trainee. Ryerson University, Canada 2018 Dana Geerts, MSc Neuropsychology, Maastricht University 2018 Manca Peskar, MSc Neuropsychology, Maastricht University 2017 Hannes Kettner, MSc Neuropsychology, Maastricht University 2017 Hannah Douglas, BSc Neuroscience, Leeds University 2017 Lea Mertens, MSc Neuropsychology, Maastricht University 2017 Laura Kartner, MSc Psychology, Julius-Maxmimilians-Universität Würzburg
3 2016 Cammy Mitchell, BSc Medicine, University of Cambridge 2016 Eline Haijin, MSc Neuropsychology, Maastricht University 2016 Anhjili Zhuparris, MSc Neuroscience, University of Amsterdam 2016 Philip Ashton, BSc Neuroscience, University of Aberdeen 2016 Sophie-Anne Fluri, MRes Experimental Neuroscience 2016 Bruna Cunha, BSc Pharmacology, UCL 2015 Lily Fitzgerald, Cambridge University, Biomedical student 2015 Jack Stroud, Oxford University, Biomedical student 2015 Catherine Scrace, BSc Neuroscience, Leeds University 2014 Dr Eduardo Schenberg. Visiting postdoc from Sao Paulo 2013 Rosa Sun, Cambridge University Medical Student 2012 Mendel Kaelen, MSc Neuroscience, University of Groningen 2012 Luke Williams, MSc Neuroscience, Birkbeck, University of London 2011 Ann-Mari Lilleløkken, MSc Mental Health Studies, Institute of Psychiatry, KCL 2011 Samuel Turton, Final year medical student, Sheffield University
SELECTION OF INVITED INTERNATIONAL PRESENTATIONS (Bold = keynote or plenary): 2021 Columbia University, College of Physicians and Surgeons, Grand Rounds, NYC, USA 2021 University of Texas at Houston, Student Seminar, USA 2020 University of Arkansas for Medical Sciences, Grand Rounds, USA 2020 10th Annual Peter Miller Musser Lecture in Depression. MGH Grand Rounds, Boston, USA 2020 Collision, Toronto, Canada 2020 Web Summit, Lisbon, Portugal 2020 Psych Congress, Nashville, USA 2020 NACCME, Las Vegas, USA 2020 Horizon, NYC, USA 2020 City Arts & Literature, San Francisco, USA 2020 Mind Medicine, Melbourne, Australia 2020 Radcliffe Institute, Harvard University, Cambridge, USA 2020 Harvard University, Boston, USA 2020 Dartmouth, Hanover, USA 2019 Web Summit, Lisbon, Portugal 2019 British Embassy, Lisbon, Portugal, Speaker for GREAT Briton’s initiative 2019 Milken Institute Global Conference, keynote speaker LA, USA 2019 Flor-Henry keynote Speaker, Edmonton, Canada 2019 ECNP invited presentation, Copenhagen, Denmark 2019 Keynote, World Economic Forum, Davos, Switzerland 2018 Keynote, Psych Congress, Orlando, USA 2018 Keynote, Psychedelic Psychotherapy Forum Victoria British Columbia, Canada 2018 Keynote, Harvard Medical School, USA 2018 Keynote, Special Lecture, University of British Columbia, Vancouver, Canada 2018 International Society for Affective Disorders, Houston, Texas, USA 2018 CINP, Vienna, Austria 2018 American Society for Clinical Psychopharmacology (ASCP), Miami, USA 2018 Los Angeles Psychedelic Symposium, LA, USA 2018 Science of Consciousness conference, Tucson, Arizona, USA 2018 BF Skinner Lecturer: Association for Behavior Analysis International (ABAI), San Diego, USA 2017 Guest Lecture at University of Toronto Dept Psychiatry, Canada 2017 Max Planck Society Visions in Science conference, Max Planck Institute, Berlin, Germany 2017 Brain and Mind meeting, University of Helsinki, Finland 2017 MAPS International conference: Oakland, California, USA 2017 International Convention of Psychological Science, Vienna, Austria 2016 Sjobring Lecture, Lund University, Sweden 2016 Keynote, University of Michigan, USA 2016 University of Wisconsin-Madison, USA 2016 Nights conference, Berlin, Germany 2016 Keynote, Karolinska Institute, Stockholm, Sweden 2016 ECNP annual congress, Vienna, Austria 2016 Interdisciplinary conference for psychedelic research, Amsterdam, Netherlands 4 2016 Centre for consciousness research, Arizona, USA 2015 American College of Neuropsychopharmacology, ACNP, Florida, USA 2015 Horizons: New perspectives on psychedelics in medicine, New York, USA 2015 Association for the scientific study of consciousness, Paris, France 2015 Society of Neuroscience, Buenos Aires, Argentina 2015 Cimbi Symposium, Copenhagen, Denmark 2015 Keynote, Champalimaud hospital, Lisbon, Portugal 2015 Keynote, Czech psychedelic society. Brno/Prague, Czech Republic 2015 Keynote, Irish psychedelic society, Dublin, Ireland 2015 Keynote, SINAPSA, Ljubljana, Slovenia 2014 Studying Consciousness in Developmental age, Rome, Italy 2014 European Congress of Psychiatry, Munich, Germany 2014 Bergen Student Society in Bergen, Norway 2013 Neuroday, Copenhagen, Denmark 2013 International Symposium on Medicinal Plants in Psychiatry, University of São Paolo, Brazil 2013 The Brain: criticality, dynamics, networks and function, University of Naples, Italy 2013 MAPS: ‘Psychedelic Science’, Oakland California, USA 2012 Keynote, NIH, Bethesda, Maryland, USA 2012 Towards a Science of Consciousness, Plenary, Tuscon, Arizona, USA 2011 MAPS International Conference: San Jose, California, USA 2011 Neuropsychoanalysis annual international symposium, Berlin, Germany 2011 Dept. of Epileptology, University of Bonn, Germany
SELECTION OF INVITED PRESENTATIONS IN UK (Bold = keynote or plenary): 2020 Royal College of Psychiatrists, London 2020 British Neuropsychiatry Association (BNPA), London 2019 CUBRIC 2, Cardiff University 2019 Conduit Club, London 2019 Founders Forum, HeathTech, Havas, London 2019 Royal College Psychiatrists International Conference, Excel, London 2019 International Psychoanalysis Association Conference, London 2018 University of Cambridge, Behavioural and Clinical Neuroscience Institute 2018- Royal Institution, London. Chairing ‘How to Change your Mind’ – Michael Pollan 2018 Wired Health, Crick Institute, London 2017 Royal College of Psychiatrists annual adult psychiatry meeting, Gateshead 2017 Cheltenham Science Festival 2017 International Society on Affective Disorders, KCL 2017 New Scientist Live – The Excel 2017 Royal College of Psychiatrists, Philosophy Special Interest meeting, London 2017 Royal College of Psychiatrists, - International Congress, Edinburgh 2016 Royal College of Psychiatrists, neuroscience interest group 2016 “Twilight Science” – The Royal Society, London 2016 “LSD Revealed” - The Royal Society, London 2016 TEDx - University of Warwick 2016 BAP, Annual meeting, Brighton 2015 “How to change the world”, The Royal Institute, London 2015 British Neuroscience Association, Annual meeting, Edinburgh 2015 British Association for Psychopharmacology, Annual meeting, Bristol 2014 Centre for Cognitive Science, University of Sussex 2014 Society for General Microbiology (SGM) Annual Conference, Liverpool 2013 Institute of Psychiatry, KCL 2013 University of Liverpool, John Moores 2013 University Dept. of Pharmacology, Oxford University 2013 British Neuropsychiatry Association annual meeting, London 2012 Association for the Scientific Study of Consciousness meeting in Brighton 2012 Brain meeting: Functional Imaging Laboratory, UCL
SELECTION OF PUBLIC ENGAGEMENT INITIATIVES: 2021 TIME NEXT 100: https://time.com/collection/time100-next-2021/5937720/robin-carhart-harris/ 5 2020 Science power list (top 31 medical scientists): https://www.thetimes.co.uk/article/from-pandemics-to- cancer-the-science-power-list-d23bb9b2k 2020 Wired World 2021 – commissioned piece: https://www.wired.co.uk/article/psychedelics-big-pharma 2020 Personally commissioned piece for The Guardian: https://www.theguardian.com/commentisfree/2020/jun/08/psychedelic-drugs-treat-depression 2020 Sean Caroll podcast: https://www.preposterousuniverse.com/podcast/2020/02/03/82-robin-carhart-harris- on-psychedelics-and-the-brain/ 2020 Daniel Carcillo podcast: https://www.youtube.com/watch?v=VMIHlM8vB74 2019 The Telegraph: https://www.telegraph.co.uk/health-fitness/mind/can-magic-mushrooms-really-cure- depression/ 2019 The Independent: https://www.independent.co.uk/news/health/magic-mushroom-depression-psychedelic- drug-mental-health-antidepressant-big-pharma-imperial-lsd-dmt-a8929796.html 2019 Guardian: https://www.theguardian.com/science/2019/jun/10/magic-mushrooms-treatment-depression- aztecs-psilocybin-mental-health-medicine 2018 The Times: https://www.thetimes.co.uk/article/could-you-treat-your-depression-by-tripping-on-magic- mushrooms-fgh672l5k 2018 Wired: http://www.wired.co.uk/article/psychedelics-lsd-depression-anxiety-addiction 2018 Magic medicine documentary: https://vimeo.com/ondemand/magicmedicine 2017 Russell Brand Podcast interview: https://www.youtube.com/watch?v=O9vNDRGveYs 2017 Guardian: https://www.theguardian.com/us-news/2017/nov/25/magic-mushrooms-decriminalization- california 2017 New Scientist: https://www.newscientist.com/round-up/psychedelic- medicine/?intcmp=PAC%7CNSNS%7C2017-inlinelink_main- feat&utm_medium=PAC&utm_source=Twitter&utm_campaign=Echobox&cmpid=SOC%7CNSNS%7C2 017-Echobox 2017 National Geographic: Breakthrough – episode 1: Addiction: Psychedelic cure? http://channel.nationalgeographic.com/breakthrough-series/episodes/addiction-a-psychedelic-cure/ 2017 The Independent: http://www.independent.co.uk/news/science/lsd-first-evidence-higher-level- consciousness-hallucinogenic-drug-scientists-a7690366.html 2016 TIME: http://time.com/4338947/magic-mushrooms-for-depression/ 2016 Newsnight: https://www.youtube.com/watch?v=JHbVSclR5qk 2016 TEDx Warwick: https://www.youtube.com/watch?v=MZIaTaNR3gk 2016 CNN: http://edition.cnn.com/videos/tv/2016/04/13/exp-lsd-researcher.cnn 2016 Today Programme, BBC Radio 4: http://www.bbc.co.uk/programmes/p03qsx61 2016 Telegraph: http://www.telegraph.co.uk/news/science/12146975/Taking-LSD-leads-to-improved- psychological-wellbeing-study.html 2015 How to Change the World - Michael Pollan (Royal Institution): https://vimeo.com/154290924 2015 The Guardian: http://www.theguardian.com/society/2015/apr/26/lsd-amanda-feilding-depression-anxiety- science 2015 The New Yorker: http://www.newyorker.com/magazine/2015/02/09/trip-treatment 2014 Independent on Sunday, Cover Story in New Review magazine: http://www.independent.co.uk/news/people/dr-robin-carhartharris-is-the-first-scientist-in-over-40-years-to- test-lsd-on-humans--and-youre-next-9667532.html 2014 The Observer: http://www.theguardian.com/society/2014/oct/05/healing-trip-psychedelic-drugs-treat- depression 2014 Sciencemag.org: https://www.sciencemag.org/content/345/6192/18.full.pdf 2014 CNN: http://edition.cnn.com/2014/09/17/health/magic-mushroom-chemical-depression/ 2014 The Conversation: https://theconversation.com/magic-mushrooms-expand-your-mind-and-amplify-your-brains-dreaming- areas-heres-how-28754 2014 Washington Post: http://www.washingtonpost.com/news/to-your-health/wp/2014/07/03/psychedelic-drugs- put-your-brain-in-a-waking-dream-study-finds/ 2014 Daily Mail: http://www.dailymail.co.uk/health/article-2679030/Are-magic-mushrooms-key-treating- depression-Brain-scans-reveal-psychedelic-drug-trips-induce-optimistic-dream-like-thinking.html 2014 Wall Street Journal article, “Psychedelics lead to a new vision of consciousness”: http://online.wsj.com/news/articles/SB10001424052702304626804579362953234754182 2014 Wellcome Trust: “Edges of consciousness” drama & science initiative. Radio drama commissioned & broadcast: https://www.bbc.co.uk/programmes/b06j67y0 2013 Daily Telegraph: http://www.telegraph.co.uk/science/9565026/Can-LSD-cure-depression.html 6 2013 Scientific American Mind: http://www.scientificamerican.com/article.cfm?id=hallucinogens-could-ease- existential-terror 2013 Wired: http://www.wired.com/wiredscience/2013/04/psychedlic/all/ 2013 Imperial Festival: http://www.youtube.com/watch?v=jT5dZDnJ6J4 2013 London Real interview: http://www.youtube.com/watch?v=GMjtAu1JqOg 2013 IAm Q&A on Reddit.com. http://www.reddit.com/r/IAmA/comments/19j3fp/iam_dr_robin_carhartharris_from_imperial_college/ 2012 Open Foundation: https://www.youtube.com/watch?v=uMRG5KFZkKw 2012 Imperial College London re MDMA research: https://www.youtube.com/watch?v=CX5Uw4-bW-o 2012 Science of Consciousness. Tuscon, Arizona. https://www.youtube.com/watch?v=s7aieKPyP8c 2012 BBC news, live interview: http://www.bbc.co.uk/news/health-16694061 2012 Channel 4: Drugs Live: the MDMA trial: http://www.youtube.com/watch?v=4coPYeGs2y4 2011 BBC 2, The Brain – a secret history: http://www.youtube.com/watch?v=gWM09s5_Z-A 2012-18 Regular Speaker for Pint of Science & Imperial Festival
PUBLICATION LIST (not including papers in prep or under review): ** = over 500 citations * = over 250 citations
106. Simonsson O, Hendricks PS, Carhart-Harris R, Kettner H, Osika W (2021) Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year. Hypertension doi: 10.1161/HYPERTENSIONAHA.120.16715.
105. Szigeti B, Kartner L, Blemings A, Rosas F, Feilding A, Nutt DJ, Carhart-Harris RL, Erritzoe D (2021) Self-blinding citizen science to explore psychedelic microdosing. Elife 10:e62878. doi: 10.7554/eLife.62878.
104. Jobst BM, Atasoy S, Ponce-Alvarez A, Sanjuán A, Roseman L, Kaelen M, Carhart-Harris R, Kringelbach ML, Deco G (2021) Increased sensitivity to strong perturbations in a whole-brain model of LSD. Neuroimage. doi: 10.1016/j.neuroimage.2021.117809.
103. Pallavicini C, Cavanna F, Zamberlan F, de la Fuente LA, Ilksoy Y, Perl YS, Arias M, Romero C, Carhart-Harris R, Timmermann C, Tagliazucchi E (2021) Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings. J Psychopharmacol. doi: 10.1177/0269881120981384.
102. Lawrence DW, Sharma B, Griffiths RR, Carhart-Harris R (2021) Trends in the Top-Cited Articles on Classic Psychedelics. J Psychoactive Drugs 1-16. doi: 10.1080/02791072.2021.1874573.
101. Kaertner LS, Steinborn MB, Kettner H, Spriggs MJ, Roseman L, Buchborn T, Balaet M, Timmermann C, Erritzoe D, Carhart-Harris RL (2021) Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing. Sci Rep. doi: 10.1038/s41598-021-81446-7.
100. Rosas FE, Mediano PAM, Jensen HJ, Seth AK, Barrett AB, Carhart-Harris RL, Bor D (2020) Reconciling emergences: An information-theoretic approach to identify causal emergence in multivariate data. PLoS Comput Biol. 2020 doi: 10.1371/journal.pcbi.1008289.
99. Luppi AI, Carhart-Harris RL, Roseman L, Pappas I, Menon DK, Stamatakis EA (2020) LSD alters dynamic integration and segregation in the human brain. Neuroimage. doi: 10.1016/j.neuroimage.2020.117653.
98. Rosas FE, Mediano PAM, Jensen HJ, Seth AK, Barrett AB, Carhart-Harris RL, Bor D (2020) Reconciling emergences: An information-theoretic approach to identify causal emergence in multivariate data. PLoS Comput Biol. doi: 10.1371/journal.pcbi.1008289.
97. Gandy S, Forstmann M, Carhart-Harris RL, Timmermann C, Luke D, Watts R (2020) The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health. Health Psychol Open. doi: 10.1177/2055102920978123.
96. Sanz C, Pallavicini C, Carrillo F, Zamberlan F, Sigman M, Mota N, Copelli M, Ribeiro S, Nutt D, Carhart-Harris R, Tagliazucchi E (2020) The entropic tongue: Disorganization of natural language under LSD. Conscious Cogn. doi: 10.1016/j.concog.2020.103070.
7 95. Brouwer A, Carhart-Harris RL (2020) Pivotal mental states. J Psychopharmacol doi: 10.1177/0269881120959637.
94. Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D (2020) Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies. Acta Psychiatr Scand. doi: 10.1111/acps.13249.
93. Herzog R, Mediano PAM, Rosas FE, Carhart-Harris R, Perl YS, Tagliazucchi E, Cofre R (2020) A mechanistic model of the neural entropy increase elicited by psychedelic drugs. Sci Rep 10(1):17725. doi: 10.1038/s41598-020-74060- 6.
92. Alamia A, Timmermann C, VanRullen R, Carhart-Harris RL (2020) DMT alters cortical travelling waves. Elife. doi: 10.7554/eLife.59784.
91. Leptourgos P, Fortier-Davy M, Carhart-Harris R, Corlett PR, Dupuis D, Halberstadt AL, Kometer M, Kozakova E, LarØi F, Noorani TN, Preller KH, Waters F, Zaytseva Y, Jardri R (2020) Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison. Schizophr Bull doi: 10.1093/schbul/sbaa117
90. Zeifman RJ, Wagner AC, Watts R, Kettner H, Mertens LJ, Carhart-Harris RL (2020) Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation. Front Psychiatry. 782. doi: 10.3389/fpsyt.2020.00782
89. Spriggs MJ, Kettner H, Carhart-Harris RL (2020) Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder. Eat Weight Disord. doi: 10.1007/s40519-020-01000-8.
88. Nutt D, Carhart-Harris R (2020) The Current Status of Psychedelics in Psychiatry. JAMA Psychiatry. doi: 10.1001/jamapsychiatry.2020.2171.
87. Varley TF, Carhart-Harris R, Roseman L, Menon DK, Stamatakis EA (2020) Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains. Neuroimage.
86. Borissova A, Ferguson B, Wall MB, Morgan CJ, Carhart-Harris RL, Bolstridge M, Bloomfield MA, Williams TM, Feilding A, Murphy K, Tyacke RJ, Erritzoe D, Stewart L, Wolff K, Nutt D, Curran HV, Lawn W (2020) Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment. J Psychopharmacol 269881120926673.
85. Kringelbach ML, Cruzat J, Cabral J, Knudsen GM, Carhart-Harris R, Whybrow PC, Logothetis NK, Deco G (2020) Dynamic coupling of whole-brain neuronal and neurotransmitter systems. Proc Natl Acad Sci U S A. 117(17):9566-9576. doi: 10.1073/pnas.1921475117
84. Nutt D, Erritzoe D, Carhart-Harris R (2020) Psychedelic Psychiatry's Brave New World. Cell. 181(1):24-28. doi: 10.1016/j.cell.2020.03.020.
83. Girn M, Mills C, Roseman L, Carhart-Harris RL, Christoff K (2020) Updating the dynamic framework of thought: Creativity and psychedelics. Neuroimage 116726.
82. Mertens LJ, Wall MB, Roseman L, Demetriou L, Nutt DJ, Carhart-Harris RL (2020) Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression. J Psychopharmacol 34(2):167-180.
81. Kettner H, Gandy S, Haijen ECHM, Carhart-Harris RL (2019) From Egoism to Ecoism: Psychedelics Increase Nature Relatedness in a State-Mediated and Context-Dependent Manner. Int J Environ Res Public Health 16(24). pii: E5147
80. Barnett L, Muthukumaraswamy SD, Carhart-Harris RL, Seth AK (2019) Decreased directed functional connectivity in the psychedelic state. Neuroimage 116462.
79. Family N, Maillet EL, Williams LTJ, Krediet E, Carhart-Harris RL, Williams TM, Nichols CD, Goble DJ, Raz S (2019) Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers. Psychopharmacology (Berl).
8 78. Timmermann C, Roseman L, Schartner M, Milliere R, Williams L, Erritzoe D, Muthukumaraswamy S, Ashton M, Bendrioua A, Kaur O, Turton S, Nour M, Day C, Leech R, Nutt D and Carhart-Harris R (2019) Neural correlates of the DMT experience assessed with multivariate EEG. Scientific Reports.
77. Roseman L, Haijen E, Idialu-Ikato K, Kaelen M, Watts R, Carhart-Harris R (2019) Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory. J Psychopharmacol.
76. Pallavicini C, Vilas MG, Villarreal M, Zamberlan F, Muthukumaraswamy S, Nutt D, Carhart-Harris R, Tagliazucchi E (2019) Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives. Neuroimage. 200:281-291.
75. Russ SL, Carhart-Harris RL, Maruyama G, Elliott MS (2019) Replication and extension of a model predicting response to psilocybin. Psychopharmacology (Berl).
74. Lord LD, Expert P, Atasoy S, Roseman L, Rapuano K, Lambiotte R, Nutt DJ, Deco G, Carhart-Harris RL, Kringelbach ML, Cabral J (2019) Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin. Neuroimage 199:127-142.
73. Carhart-Harris RL & Friston KJ (2019) REBUS and the anarchic brain: towards a unified model on the brain action of psychedelics. Pharmacological Reviews.
72. Scott G & Carhart-Harris R (2019) Psychedelics for disorders of consciousness. Journal of Consciousness Research.
71. Atasoy S, Vohryzek J, Deco G, Carhart-Harris RL, Kringelbach ML (2018) Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition. Prog Brain Res 242:97-120.
70. Carhart-Harris RL (2018) How do psychedelics work? Current Opinion in Psychiatry.
69. Haijen EC, Kaelen M, Roseman L, Timmermann C, Russ C, Nutt D, Daws RE, Hampshire AD, Lorenz R, Carhart- Harris RL (2018) Predicting responses to psychedelics: a prospective study. Front Psychol.
68. Lyons T & Carhart-Harris RL (2018) More Realistic Forecasting of Future Life Events After Psilocybin For Treatment-Resistant Depression. Front Psychol.
67. Deco G, Cruzat J, Cabral J, Knudsen GM, Carhart-Harris RL, Whybrow PC, Logothetis NK, Kringelbach ML (2018) Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD. Curr Biol. 28(19):3065-3074.e6.
66. Millière R, Carhart-Harris RL, Roseman L, Trautwein FM, Berkovich-Ohana A (2018) Psychedelics, Meditation, and Self-Consciousness. Front Psychol.
65. Carhart-Harris RL (2018) Serotonin, psychedelics and psychiatry. World Psychiatry. 17(3):358-359.
64. Timmermann C, Roseman L, Williams L, Erritzoe D, Martial C, Cassol H, Laureys S, Nutt D, Carhart-Harris R (2018) DMT Models the Near-Death Experience. Front Psychol. 9:1424.
63. Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, Carhart-Harris RL (2018) Effects of psilocybin therapy on personality structure. Acta Psychiatr Scand.
62. Gabay AS, Carhart-Harris RL, Mazibuko N, Kempton MJ, Morrison PD, Nutt DJ, Mehta MA (2018) Psilocybin and MDMA reduce costly punishment in the Ultimatum Game. Sci Rep 8(1):8236
61. Carhart-Harris RL (2018) The entropic brain - revisited. Neuropharmacology. pii: S0028-3908(18)30117-5.
60. Carhart-Harris RL, Roseman L, Haijen E, Erritzoe D, Watts R, Branchi I, Kaelen M (2018) Psychedelics and the essential importance of context. J Psychopharmacol. 2018 Feb 1:269881118754710. doi: 10.1177/0269881118754710.
9 59. Carrillo F, Sigman M, Fernández Slezak D, Ashton P, Fitzgerald L, Stroud J, Nutt DJ, Carhart-Harris RL (2018) Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression. J Affect Disord. 2018 Apr 1;230:84-86. doi: 10.1016/j.jad.2018.01.006.
58. Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart- Harris R (2018) The hidden therapist: evidence for a central role of music in psychedelic therapy. Psychopharmacology (Berl). 235(2):505-519. doi: 10.1007/s00213-017-4820-5.
57. Roseman L, Nutt DJ, Carhart-Harris RL (2018) Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression. Front Pharmacol.8:974. doi: 10.3389/fphar.2017.00974. eCollection 2017.
56. Roseman L, Demetriou L, Wall MB, Nutt DJ, Carhart-Harris RL (2017) Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. Neuropharmacology. pii: S0028-3908(17)30639-1. doi: 10.1016/j.neuropharm.
55. Atasoy S, Roseman L, Kaelen M, Kringelbach M, Deco G, Carhart-Harris RL (2017) Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD. Sci Rep.
54: Lyons T & Carhart-Harris RL (2017) Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression. J Psychopharmacol.
53: Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ (2017) Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology (Berl).
52: Timmermann C, Spriggs MJ, Kaelen M, Leech R, Nutt DJ, Moran RJ, Carhart-Harris RL, Muthukumaraswamy SD (2017) LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm. Neuropharmacology. pii: S0028-3908(17)30506-3.
51: Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ, Curran HV, Carhart-Harris RL (2017) Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression. Psychopharmacology (Berl). [Epub ahead of print]
50: Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ (2017) Psilocybin for treatment-resistant depression: fMRI- measured brain mechanisms. Sci Rep. 13;7(1):13187.
49: Carhart-Harris RL, Nutt DJ (2017) Serotonin and brain function: a tale of two receptors. J Psychopharmacol. 31(9):1091-1120.
48: Carhart-Harris RL, Erritzoe D, Haijen E, Kaelen M, Watts R (2017) Psychedelics and connectedness. Psychopharmacology (Berl)
47. Watts R, Day C, Krzanowski J, Nutt, DJ, Carhart-Harris RL (2017) Patients' accounts of increased 'connection' and 'acceptance' after psilocybin for treatment-resistant depression. Journal of Humanistic Psychology.
46. Nour MM, Evans L, Carhart-Harris RL (2017) Psychedelics, Personality and Political Perspectives. J Psychoactive Drugs. 2017 Apr 26:1-10. doi: 10.1080/02791072.2017.1312643. [Epub ahead of print]
45. Carhart-Harris RL & Goodwin GM (2017) The Therapeutic Potential of Psychedelic Drugs: Past, Present and Future. Neuropsychopharmacology. doi: 10.1038/npp.2017.84. [Epub ahead of print]
44. Schartner MM, Carhart-Harris RL, Barrett AB, Seth AK, Muthukumaraswamy SD (2017) Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin. Nature Sci Rep. 7:46421. doi: 10.1038/srep46421.
43. Walpola IC, Nest T, Roseman L, Erritzoe D, Feilding A, Nutt DJ, Carhart-Harris RL (2017) Altered Insula Connectivity under MDMA. Neuropsychopharmacology. doi: 10.1038/npp.2017.35. 10
42. Carhart-Harris RL & Nutt DJ (2016) Response to Letter ‘Question based drug development for psilocybin’. Lancet Psychiatry. 3(9):807. doi: 10.1016/S2215-0366(16)30217-6.
**41. Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ. (2016) Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 3(7):619-27. doi: 10.1016/S2215-0366(16)30065-7.
40. Nour MM & Carhart-Harris RL (2016) Psychedelics and the science of self-experience. British Journal of Psychiatry. 210(3):177-179. doi: 10.1192/bjp.bp.116.194738.
39. Nour MM, Evans L, Nutt D and Carhart-Harris RL (2016) Ego-Dissolution and Psychedelics: Validation of the Ego- Dissolution Inventory (EDI). Front. Hum. Neurosci. 10:269. doi:10.3389/fnhum.2016.0026938.
38. Family N, Vinson D, Vigliocco G, Kaelen M, Bolstridge M, Nutt DJ, Carhart-Harris RL (2016). Semantic activation in LSD: evidence from picture naming. Language, Cognition and Neuroscience.
37: Lebedev AV, Kaelen M, Lövdén M, Nilsson J, Feilding A, Nutt DJ, Carhart-Harris RL (2016) LSD-induced entropic brain activity predicts subsequent personality change. Hum Brain Mapp. doi: 10.1002/hbm.23234.
36: Roseman L, Sereno MI, Leech R, Kaelen M, Orban C, McGonigle J, Feilding A, Nutt DJ, Carhart-Harris RL (2016) LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion. Hum Brain Mapp. doi: 10.1002/hbm.23224.
35: Tagliazucchi E, Roseman L, Kaelen M, Orban C, Muthukumaraswamy SD, Murphy K,Laufs H, Leech R, McGonigle J, Crossley N, Bullmore E, Williams T, Bolstridge M, Feilding A, Nutt DJ, Carhart-Harris RL (2016) Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution. Curr Biol. 25;26(8):1043-50. doi: 10.1016/j.cub.2016.02.010.
34: Kaelen M, Roseman L, Kahan J, Santos-Ribeiro A, Orban C, Lorenz R, Barrett FS, Bolstridge M, Williams T, Williams L, Wall MB, Feilding A, Muthukumaraswamy S, Nutt DJ, Carhart-Harris RL (2016) LSD modulates music-induced imagery via changes in parahippocampal connectivity. Eur Neuropsychopharmacol. pii: S0924-977X(16)30016-5. doi: 10.1016/j.euroneuro.2016.03.018.
*33: Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, Tagliazucchi E, Schenberg EE, Nest T, Orban C, Leech R, Williams LT, Williams TM, Bolstridge M, Sessa B, McGonigle J, Sereno MI, Nichols D, Hellyer PJ, Hobden P, Evans J, Singh KD, Wise RG, Curran HV, Feilding A, Nutt DJ (2016) Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci U S A. 113(17):4853-8. doi: 10.1073/pnas.1518377113.
32: Terhune DB, Luke DP, Kaelen M, Bolstridge M, Feilding A, Nutt D, Carhart-Harris RL, Ward J (2016) A placebo- controlled investigation of synaesthesia-like experiences under LSD. Neuropsychologia. pii: S0028-3932(16)30113-0. doi: 10.1016/j.neuropsychologia.2016.04.005.
31: Speth J, Speth C, Kaelen M, Schloerscheidt AM, Feilding A, Nutt DJ, Carhart-Harris RL (2016) Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide. J Psychopharmacol 30(4):344-53. doi: 10.1177/0269881116628430.
30. Carhart-Harris RL, Kaelen M, Bolstridge M, Williams TM, Williams LT, Underwood R, Feilding A, Nutt DJ (2016) The paradoxical psychological effects of lysergic acid diethylamide (LSD). Psychol Med 5:1-12.
29. Kaelen M, Barrett F, Roseman L, Lorenz R, Family N, Bolstridge M, Curran V, Feilding A, Nutt DJ, Carhart-Harris RL (2015) LSD enhances the emotional response to music. Psychopharmacology 232(19):3607-14.
28. Lebedev AV, Lövdén M, Rosenthal G, Feilding A, Nutt DJ, Carhart-Harris RL (2015) Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin. Hum Brain Mapp. doi: 10.1002/hbm.22833
27. Steeds H, Carhart-Harris RL, Stone JM (2015) Drug models of schizophrenia. Ther Adv Psychopharmacol. 2015 Feb;5(1):43-58. doi: 10.1177/2045125314557797 11
26. Turton S, Nutt DJ, Carhart-Harris RL (2015) A Qualitative Report on the Subjective Experience of Intravenous Psilocybin Administered in an fMRI Environment. Curr Drug Abuse Rev.
25. Carhart-Harris RL, Kaelen M, Whalley M, Bolstridge M, Feilding A, Nutt DJ (2014) LSD enhances suggestibility in healthy volunteers. Psychopharmacology. doi: 10.1007/s00213-014-3714-z.
24. Carhart-Harris RL, Kaelen M, Nutt DJ (2014) How do hallucinogens work on the brain? The Psychologist. 27 (9).
23. Carhart-Harris RL & Nutt (2014) Was it a vision or a waking dream? Frontiers in Psychology. doi: 10.3389/fpsyg.2014.00255.
22. Roseman L, Leech R, Feilding A, Nutt DJ, Carhart-Harris RL (2014) The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers. Frontiers in Human Neuroscience. doi: 10.3389/fnhum.2014.00204.
*21. Muthukumuraswarmy S, Carhart-Harris RL*, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ et al. (2013) Broadband cortical desynchronization underlies the human psychedelic state. J Neuroscience 33(38):15171-83. doi: 10.1523/JNEUROSCI.2063-13.2013. * Shared first authors.
20. Carhart-Harris RL, Murphy K, Leech R, Erritzoe D, Wall MB, Ferguson B, Williams LT, Roseman L, Brugger S, De Meer I, Tanner M, Tyacke R, Wolff K, Sethi A, Bloomfield MA, Williams TM, Bolstridge M, Stewart L, Morgan C, Newbould RD, Feilding A, Curran HV, Nutt DJ (2014) The effects of acutely administered MDMA on spontaneous brain function measured with arterial spin labelling and BOLD resting-state functional connectivity. Biol Psych. doi: 10.1016/j.biopsych.2013.12.015.
19. Carhart-Harris RL, Wall MB, Erritzoe D, Kaelen M, Ferguson B, De Meer I, Tanner M, Bloomfield M, Williams TM, Bolstridge M, Stewart L, Morgan CJ, Newbould RD, Feilding A, Curran HV, Nutt DJ (2013) The effect of MDMA on recollecting autobiographical memories: an fMRI study with implications for MDMA-assisted psychotherapy. Int J Neuropsychopharmacology 17:1-14. doi: 10.1017/S1461145713001405.
**18. Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, Chialvo DR, Nutt DJ. (2014) The entropic brain: A theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in Human Neuroscience. doi: 10.3389/fnhum.2014.00020.
17. Tagliazucchi E, Carhart-Harris RL, Nutt DJ, Chialvo D (2014) Enhanced repertoire of brain dynamical states during the psychedelic experience. Human Brain Mapping. doi: 10.1002/hbm.22562
16. Leech R, Scott G, Carhart-Harris RL, Turkheimer F, Taylor-Robinson S, Sharp D (2013) A spatial relationship between task positive and task negative networks. PloS One.
*15. Petri G, Expert P, Turkheimer F, Hellyer P, Carhart-Harris RL et al. (2014) Homological backbone of brain functional networks. J R Soc Interface. 11(101).
14. Carhart-Harris RL, Nutt DJ, Stone JM (2013) Psychiatry’s next top-model: Cause for a re-think on drug models of psychosis and other psychiatric disorders. Journal of Psychopharmacology 27(9):771-8.
13. Carhart-Harris RL & Nutt DJ (2013) Experienced drug users assess the relative harms and benefits of drugs: a web- based survey. Journal of Psychoactive drugs 45(4):322-8.
**12. Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, Tyacke RJ, Leech R, Malizia AL, Murphy K, Hobden P, Evans J, Feilding A, Wise RG, Nutt DJ (2012) Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci U S A 109:2138-43.
11. Carhart-Harris RL, R. Leech, D. Erritzoe, T. M. Williams, J. M. Stone, J. Evans, D. J. Sharp, A. Feilding, R. G. Wise, and D. J. Nutt (2012) Functional Connectivity Measures after Psilocybin Inform a Novel Hypothesis of Early Psychosis. Schizophr Bull 39(6):1343-51.
12 10. Carhart-Harris RL, Leech R, Williams TM, Erritzoe D, Abbasi N, Bargiotas T, Hobden P, Sharp DJ, Evans J, Feilding A, Wise RG, Nutt DJ (2012) Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. Br J Psychiatry. 200(3):238-44.
9. Carhart-Harris RL & Friston KJ (2012) Free-energy and Freud: an update. Ch 13. From the couch to the lab: Trends in psychodynamic neuroscience. Ed. Fotopoulou A et al. Oxford Books.
8. Carhart-Harris RL, King LA, Nutt DJ (2011) A web-based survey on mephedrone. Drug Alcohol Depend 118(1):19- 22.
*7. Carhart-Harris RL, Friston KJ (2010) The default-mode, ego-functions and free energy: a neurobiological account of Freudian ideas. Brain 133(4):1265-83.
6. Carhart-Harris RL, Williams TM, Sessa B, Tyacke R, Feilding A, Nutt DJ (2010) The administration of psilocybin to healthy hallucinogen-experienced volunteers in a mock-fMRI environment: a preliminary investigation of tolerability. Journal of Psychopharmacology. 25(11):1562-7.
5. Carhart-Harris RL & Nutt DJ (2010) User perceptions of the benefits and harms of hallucinogenic drug use: a web- based questionnaire study. Journal of Substance Use 15(4) 283-300.
4. Carhart-Harris RL, Nutt DJ, Munafo MR, Christmas DM, Wilson SJ (2009) Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls. Psychopharmacology (Berl) 206(2):187-96
3. Carhart-Harris RL, Nutt DJ, Munafo M, Wilson SJ (2009) Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study. J Psychopharmacol 23(3):249-57
2. Carhart-Harris RL, Mayberg HS, Malizia ML, Nutt D J (2008) Mourning & Melancholia revisited: Correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatry. Annals of General Psychiatry 7 (1): 9.
1. Carhart-Harris RL (2007) Waves of the unconscious. The neurophysiology of dreamlike phenomena and its implications for the psychodynamic model of the mind. Neuropsychoanalysis 9 (2):183-211.
Robin Carhart-Harris, PhD
13